Page last updated: 2024-08-24

clinafloxacin and Bacterial Disease

clinafloxacin has been researched along with Bacterial Disease in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (53.85)18.2507
2000's4 (30.77)29.6817
2010's2 (15.38)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bridges, AJ; Culbertson, TP; Domagala, JM; Gambino, L; Hagen, SE; Karrick, G; Porter, K; Sanchez, JP; Sesnie, JA; Spense, FG1
Damu, GL; Geng, RX; Lv, JS; Wang, Y; Yang, DC; Zhou, CH1
Ba, Y; Hou, X; Wang, S; Xu, Z; Yang, H; Zhang, J1
Finegold, SM; Molitoris, E; Reeves, D; Wexler, HM1
Eiseman, IA; McGuire, NM; Tack, KJ1
Goldstein, EJ1
Cohen, MA; Gage, JW; Huband, MD; Roland, GE; Yoder, SL1
Deshpande, LM; Diekema, DJ; Jones, RN1
Bennion, RS; Christou, NV; Dellinger, EP; Pak, R; Rotstein, OD; Solomkin, JS; Tack, K; Wilson, SE1
Christou, N; Eiseman, I; Siami, G; Tack, KJ1
Brennscheidt, U; Cornely, O; Figuera, A; Glauser, MP; Grigg, A; Keyserling, C; Tack, K; Trostmann, U; Welling, L1
Shah, P; Tack, K; Trostmann, U1
Allen, SD; Barry, AL; Fuchs, PC; Gerlach, EH; Pfaller, MA1

Reviews

2 review(s) available for clinafloxacin and Bacterial Disease

ArticleYear
Nitroimidazole-containing compounds and their antibacterial and antitubercular activities.
    European journal of medicinal chemistry, 2019, Oct-01, Volume: 179

    Topics: Anti-Bacterial Agents; Bacterial Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Nitroimidazoles

2019
Possible role for the new fluoroquinolones (levofloxacin, grepafloxacin, trovafloxacin, clinafloxacin, sparfloxacin, and DU-6859a) in the treatment of anaerobic infections: review of current information on efficacy and safety.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996, Volume: 23 Suppl 1

    Topics: Anti-Infective Agents; Bacteria, Anaerobic; Bacterial Infections; Fluoroquinolones; Humans; Levofloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolones; Safety; Syndrome

1996

Trials

5 trial(s) available for clinafloxacin and Bacterial Disease

ArticleYear
Initial clinical experience with clinafloxacin in the treatment of serious infections.
    Drugs, 1995, Volume: 49 Suppl 2

    Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Child; Ciprofloxacin; Drug Resistance, Multiple; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Middle Aged; Quinolones

1995
Results of a clinical trial of clinafloxacin versus imipenem/cilastatin for intraabdominal infections.
    Annals of surgery, 2001, Volume: 233, Issue:1

    Topics: Abdomen; Adult; Anti-Infective Agents; Bacterial Infections; Cilastatin; Double-Blind Method; Female; Fluoroquinolones; Humans; Imipenem; Logistic Models; Male; Middle Aged; Prospective Studies; Protease Inhibitors; Thienamycins

2001
Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; beta-Lactamase Inhibitors; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fluoroquinolones; Humans; Male; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Skin Diseases, Infectious; Tazobactam

2001
Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patients.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2002, Volume: 8, Issue:1

    Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fever; Fluoroquinolones; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Teicoplanin; Treatment Outcome; Vancomycin

2002
Open-label, multicentre, emergency-use study of clinafloxacin (CI-960) in the treatment of patients with serious life-threatening infections.
    International journal of antimicrobial agents, 2002, Volume: 19, Issue:3

    Topics: Adult; Anti-Infective Agents; Bacterial Infections; Critical Illness; Cross Infection; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gastrointestinal Diseases; Humans; Male; Middle Aged; Respiratory Tract Infections; Treatment Failure

2002

Other Studies

6 other study(ies) available for clinafloxacin and Bacterial Disease

ArticleYear
Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship.
    Journal of medicinal chemistry, 1991, Volume: 34, Issue:3

    Topics: Alkylation; Aminoquinolines; Animals; Anti-Bacterial Agents; Bacterial Infections; Chemical Phenomena; Chemistry; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Hydroxyquinolines; Mice; Microbial Sensitivity Tests; Molecular Structure; Piperazines; Pyrrolidines; Structure-Activity Relationship; Topoisomerase II Inhibitors

1991
Design, synthesis and evaluation of clinafloxacin triazole hybrids as a new type of antibacterial and antifungal agents.
    Bioorganic & medicinal chemistry letters, 2012, Sep-01, Volume: 22, Issue:17

    Topics: Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Drug Design; Fluoroquinolones; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycoses; Staphylococcal Infections; Triazoles

2012
In-vitro activity of clinafloxacin (CI-960) and PD 131628-2 against anaerobic bacteria.
    The Journal of antimicrobial chemotherapy, 1994, Volume: 34, Issue:4

    Topics: Anti-Infective Agents; Bacteria, Anaerobic; Bacterial Infections; Culture Media; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Quinolones

1994
Bacterial eradication by clinafloxacin, CI-990, and ciprofloxacin employing MBC test, in-vitro time-kill and in-vivo time-kill studies.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 41, Issue:6

    Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Naphthyridines; Quinolones

1998
Comparative activity of clinafloxacin and nine other compounds tested against 2000 contemporary clinical isolates from patients in United States hospitals.
    Diagnostic microbiology and infectious disease, 1999, Volume: 35, Issue:1

    Topics: Anti-Infective Agents; Bacterial Infections; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospitals; Humans; Microbial Sensitivity Tests; United States

1999
Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolates.
    Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:4

    Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines

1991